PetVivo Holdings, Inc. (PETV)

Market Cap	12.21M
Revenue (ttm)	956.05K
Net Income (ttm)	-8.63M
Shares Out	22.20M
EPS (ttm)	-0.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Average Volume	17,964
Open	0.515
Previous Close	0.550
Day's Range	0.515 - 0.515
52-Week Range	0.290 - 1.250
Beta	2.39
RSI	43.94
Earnings Date	Jun 27, 2025

About PetVivo Holdings

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company’s pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: John Lai
• Employees: 20
• Stock Exchange: OTCMKTS
• Ticker Symbol: PETV

Financial Performance

In 2023, PetVivo Holdings's revenue was $968,706, an increase of 5.62% compared to the previous year's $917,162. Losses were -$10.96 million, 25.7% more than in 2022.